A.Vijayarajan In Conversation With RJ Kay | InnAccel | Exclusive Interview | Radio One International скачать в хорошем качестве

A.Vijayarajan In Conversation With RJ Kay | InnAccel | Exclusive Interview | Radio One International

A. Vijayarajan In Conversation With RJ Kay | InnAccel | Exlusive Interview | Radio One InternationalStay tuned for the best videos by subscribing here:    / radiooneinternational   #InnAccelTechnologies #startup #medtech #veteran #wiprohealthsciences #radiooneinternational #radioone #kay Description: InnAccel, founded by Siraj Dhanani and A Vijayarajan and funded by Bengaluru-based venture fund Mount Judi, has developed an AI-powered, fetal heart rate monitor for mothers in labour or post 36 weeks of gestation. It is based on next-gen ECG signal processing, and is said to be more accurate, reliable, and easier to use compared to conventional Doppler-based devices. It has also developed a low-cost portable device designed to provide breathing support for infants with respiratory distress. One of the winners of the Global Women’s HealthTech Awards announced at the CES conference and exhibition in Las Vegas last week. The awards are given by the World Bank Group and the Consumer Technology Association (CTA), the organiser of CES. The awards, which were given for the first time this year, recognise innovative startups that leverage tech to improve women's health and safety in emerging markets. Over 70 companies from 35 countries applied. InnAccel started in 2012 as a Medical Technology accelerator with a view to support external startups in this space. However, by 2015, we shifted focus to developing our own portfolio of products for needs identified using the Biodesign process. In 2019, InnAccel integrated operations with Coeo Labs and Sattva Medtech, former incubatees, to form a single entity with a portfolio of innovative, life-saving products across specialty areas. The Medical Device market is rapidly growing in India and across the world. Across emerging markets, this segment is expected to grow to $100 billion by 2025. We believe that these emerging markets, primarily served today by imports from developed countries, also offer an opportunity for technology innovation and novel product development to address their specific challenges. InnAccel aims to be the leader in medical technology innovation ------------------------------------------------------------------------------------------------------------------------------------------------ ❤️ Crazy for #international updates? We bring you the latest international content! Stay tuned with us and 🔔 Don’t forget to hit that notification bell! 🔔 You can also find us on: ▪️ Facebook -   / 94.3radioone   ▪️ Instagram -   / 94.3radiooneindia